Where this grouping sits
39 disease entries belong to this grouping through nested groupings. They appear in the coverage table below as nested members, are evaluated against the membership criteria like direct members, and count toward coverage.
Why this grouping
MONDO alignment & provenance
MONDO:0015286 is the broad congenital-disorder-of-glycosylation class, spanning N-linked, O-linked, GPI-anchor, and glycosphingolipid defects. That is this grouping's concept, not the narrower N-glycan concept of the nested Congenital_Disorders_of_Glycosylation child, which now carries skos:narrowMatch against the same term. MONDO descendants without DisMech entries are curation gaps rather than a reason to downgrade the predicate.
MONDO consistency: inconsistent Re-derived 2026-09-18 over all 38 transitively held members: 24 are hierarchical descendants of MONDO:0015286 and 14 are not. Recorded as INCONSISTENT because that is what was measured; the mapping predicate is deliberately left at skos:exactMatch pending a decision, and this note is the evidence for that decision rather than a pre-emption of it. Method, reproducible without a local MONDO build: each member's own MONDO term is resolved to its ancestor set via the OLS hierarchicalAncestors endpoint and MONDO:0015286 looked up in it — one bounded upward walk per member (13-38 terms) instead of one unbounded downward expansion of the class. The OAK ols:mondo adapter raises NotImplementedError for both directions, but the REST endpoint underneath answers ancestors. The 14 divide into two kinds, and only one is a defect. (1) Genuine scope difference: MONDO scopes congenital disorder of glycosylation narrower than ICIMD category 18 does. The two deglycosylation members sit under MONDO:0031376 congenital disorder of deglycosylation, a *sibling* of MONDO:0015286 beneath MONDO:0019052 inborn errors of metabolism, and five of the six GPI-anchor members are likewise outside the class. ICIMD puts both inside category 18; MONDO does not. (2) Classification by clinical presentation rather than mechanism: Dystroglycanopathy sits under muscular dystrophy, Autosomal Recessive Cutis Laxa Type 2A under cutis laxa and hereditary skin disorder (verified against its direct parents, which carry no CDG term), the SLC10A7 and EXTL3 entries under skeletal system disorder, the PIG-gene entries under the epilepsies, and VPS51-CDG under pontocerebellar hypoplasia. These are candidate MONDO term requests, not membership errors. What this means for the predicate: the umbrella's concept properly *contains* the MONDO class rather than equalling it, which is skos:broadMatch and not skos:exactMatch. The reason it has not simply been flipped is that the change is not free — per CLAUDE.md a broadMatch does not count as curated for MONDO coverage, and scripts/grouping_mondo_gaps.py derives descendant gaps only from an exactMatch, so flipping it here after the N-glycan child was downgraded to narrowMatch would leave MONDO:0015286 with no exactMatch anywhere in the family and silently end gap derivation for the whole CDG branch. Semantics and tooling disagree; that is a design call for the decision register, not a predicate to change twice in two days.
Membership criteria
- OR
The disjunction of the five nested sub-groupings' own NECESSARY criteria. Stated as a union rather than as a single broader process term because no one GO class subsumes protein glycosylation, GPI-anchor (lipid) glycosylation, and protein deglycosylation; a member satisfies this parent through whichever branch its own sub-grouping already requires.
- HAS BIOLOGICAL PROCESS
protein N-linked glycosylation GO:0006487
Involves protein N-linked glycosylation (assembly/transfer) — the Congenital_Disorders_of_Glycosylation branch.
- HAS BIOLOGICAL PROCESS
N-glycan processing GO:0006491
Involves N-glycan processing (Golgi maturation) — the Congenital_Disorders_of_Glycosylation branch.
- HAS BIOLOGICAL PROCESS
GPI anchor biosynthetic process GO:0006506
Involves GPI anchor biosynthesis — the Disorders_of_GPI_Anchor_Biosynthesis branch, ICIMD's lipid-glycosylation subdivision.
- HAS BIOLOGICAL PROCESS
protein glycosylation GO:0009101
Involves glycoprotein biosynthesis without the lesion being specific to a named branch — the Other_Multiple_Glycosylation_Pathway_Disorders branch, whose members are there precisely because their lesion spans several. Ontology closure makes this subsume the two N-linked and the O-linked operands, which are kept so a member's own branch stays readable off the criterion that matched it.
- HAS BIOLOGICAL PROCESS
protein O-linked glycosylation GO:0006493
Involves protein O-linked glycosylation — the Disorders_of_O-linked_Protein_Glycosylation branch (O-mannose, O-glucose/O-fucose, and the O-xylose glycosaminoglycan linker). Also satisfied by Other_Multiple_Glycosylation_Pathway_Disorders members whose branch-non-specific lesion reaches O-glycans.
- HAS BIOLOGICAL PROCESS
glycosaminoglycan biosynthetic process GO:0006024
Involves glycosaminoglycan biosynthesis — the GAG-*synthesis* arm that ICIMD places under O-linked protein glycosylation. Note this is biosynthesis, not the lysosomal catabolism of the mucopolysaccharidoses.
- HAS BIOLOGICAL PROCESS
protein folding in endoplasmic reticulum GO:0034975
Involves ER protein folding — carried because Other_Multiple_Glycosylation_Pathway_Disorders requires it for UGGT1, whose lesion is re-glucosylation-based quality control of N-glycans.
- HAS BIOLOGICAL PROCESS
proteoglycan biosynthetic process GO:0030166
Involves proteoglycan biosynthesis — carried because Disorders_of_O-linked_Protein_Glycosylation requires it for the two members that annotate only the proteoglycan-product classes (GO:0015012, GO:0050650) rather than the glycosaminoglycan class. Without it this disjunction was not in fact the union of its children's criteria, which is what the logic description above claims.
- HAS BIOLOGICAL PROCESS
protein deglycosylation GO:0006517
Involves protein deglycosylation — the Congenital_Disorders_of_Deglycosylation branch.
- HAS BIOLOGICAL PROCESS
oligosaccharide catabolic process GO:0009313
Involves oligosaccharide catabolism — the Congenital_Disorders_of_Deglycosylation branch (free-oligosaccharide trimming).
- HAS BIOLOGICAL PROCESS
protein N-linked glycosylation GO:0006487
- OR
A discovery criterion, not an audit of the listed members: it is stated SUFFICIENT so that entries carrying an ICIMD category-18 value but not yet reached by any nested sub-grouping surface as candidate additions. Those currently outstanding are named in notes. It is deliberately not NECESSARY — most listed members carry no icimd_category value at all, and a NECESSARY reading would report that curation gap as a membership contradiction.
- HAS CLASSIFICATION
ICIMD category 18 at the category level.
- HAS CLASSIFICATION
ICIMD 18, N-linked protein glycosylation.
- HAS CLASSIFICATION
ICIMD 18, O-linked protein glycosylation (incl. GAG synthesis).
- HAS CLASSIFICATION
ICIMD 18, lipid glycosylation (incl. GPI biosynthesis).
- HAS CLASSIFICATION
ICIMD 18, disorders affecting multiple glycosylation pathways (dolichol metabolism, Golgi transport and homeostasis, sialic acid metabolism).
- HAS CLASSIFICATION
ICIMD 18, other disorders of glycan metabolism.
- HAS CLASSIFICATION
Coverage and gaps
Exact MONDO scope: MONDO:0015286 · congenital disorder of glycosylation Completeness is counted over rows inside this exact MONDO scope that are listed in this grouping. Finer MONDO descendants under already-covered DisMech concepts are suppressed (14).
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Involves protein N-linked glycosylation (assembly/transfer) — the Congenital_Disorders_of_Glycosylation branch. GO:0006487 | C1.2 Involves N-glycan processing (Golgi maturation) — the Congenital_Disorders_of_Glycosylation branch. GO:0006491 | C1.3 Involves GPI anchor biosynthesis — the Disorders_of_GPI_Anchor_Biosynthesis branch, ICIMD's lipid-glycosylation subdivision. GO:0006506 | C1.4 Involves glycoprotein biosynthesis without the lesion being specific to a named branch — the Other_Multiple_Glycosylation_Pathway_Disorders branch, whose members are there precisely because their lesion spans several. Ontology closure makes this subsume the two N-linked and the O-linked operands, which are kept so a member's own branch stays readable off the criterion that matched it. GO:0009101 | C1.5 Involves protein O-linked glycosylation — the Disorders_of_O-linked_Protein_Glycosylation branch (O-mannose, O-glucose/O-fucose, and the O-xylose glycosaminoglycan linker). Also satisfied by Other_Multiple_Glycosylation_Pathway_Disorders members whose branch-non-specific lesion reaches O-glycans. GO:0006493 | C1.6 Involves glycosaminoglycan biosynthesis — the GAG-*synthesis* arm that ICIMD places under O-linked protein glycosylation. Note this is biosynthesis, not the lysosomal catabolism of the mucopolysaccharidoses. GO:0006024 | C1.7 Involves ER protein folding — carried because Other_Multiple_Glycosylation_Pathway_Disorders requires it for UGGT1, whose lesion is re-glucosylation-based quality control of N-glycans. GO:0034975 | C1.8 Involves proteoglycan biosynthesis — carried because Disorders_of_O-linked_Protein_Glycosylation requires it for the two members that annotate only the proteoglycan-product classes (GO:0015012, GO:0050650) rather than the glycosaminoglycan class. Without it this disjunction was not in fact the union of its children's criteria, which is what the logic description above claims. GO:0030166 | C1.9 Involves protein deglycosylation — the Congenital_Disorders_of_Deglycosylation branch. GO:0006517 | C1.10 Involves oligosaccharide catabolism — the Congenital_Disorders_of_Deglycosylation branch (free-oligosaccharide trimming). GO:0009313 | C2.1 ICIMD category 18 at the category level. | C2.2 ICIMD 18, N-linked protein glycosylation. | C2.3 ICIMD 18, O-linked protein glycosylation (incl. GAG synthesis). | C2.4 ICIMD 18, lipid glycosylation (incl. GPI biosynthesis). | C2.5 ICIMD 18, disorders affecting multiple glycosylation pathways (dolichol metabolism, Golgi transport and homeostasis, sialic acid metabolism). | C2.6 ICIMD 18, other disorders of glycan metabolism. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nested in scope |
ALG1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismALG1 is the beta-1,4-mannosyltransferase that adds the first mannose to the cytosolic-face dolichol-linked GlcNAc2 precursor; deficiency (CDG-Ik) blocks LLO assembly at its earliest mannosylation step, upstream of the ALG3/ALG9/ALG12 elongation reactions.
|
ALG1-congenital disorder of glycosylation
MONDO:0012052
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
ALG12-congenital disorder of glycosylation
DISEASE
Differentiating mechanismALG12 is a later mannosyltransferase in LLO assembly; deficiency (CDG-Ig) gives a similar N-linked assembly defect at a distinct step from ALG9.
|
ALG12-congenital disorder of glycosylation
MONDO:0011783
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
ALG3-congenital disorder of glycosylation
DISEASE
Differentiating mechanismALG3 is the first luminal-face mannosyltransferase, acting on Man5GlcNAc2-PP-dolichol after flipping; deficiency (CDG-Id) stalls LLO elongation at the cytosolic/luminal transition, a distinct step from the later luminal ALG9 and ALG12 reactions.
|
ALG3-congenital disorder of glycosylation
MONDO:0010998
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
ALG9-congenital disorder of glycosylation
DISEASE
Differentiating mechanismALG9 mannosyltransferase adds mannose residues to the lipid-linked oligosaccharide; its deficiency truncates the N-glycan precursor (CDG-Il), a classic N-linked assembly defect.
|
ALG9-congenital disorder of glycosylation
MONDO:0012117
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
B4GALT1-Congenital Disorder of Glycosylation
DISEASE
Differentiating mechanismGolgi beta-1,4-galactosyltransferase 1, which adds the galactose of the terminal N-glycan antenna. The lesion is at the outermost elongation step rather than in precursor assembly, so the entry's defining features are a coagulopathy and an altered lipoprotein profile from undergalactosylated client glycoproteins.
|
B4GALT1-congenital disorder of glycosylation
MONDO:0011772
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
CCDC115-CDG
DISEASE
Differentiating mechanismGolgi V-ATPase assembly, so the proximal lesion is Golgi luminal pH rather than any glycosyltransferase. It sits with the trafficking-and-homeostasis arm of this grouping (COG1, COG7, VPS51) and, like them, produces a combined N- and O-glycosylation defect; the distinguishing clinical feature is hepatopathy with abnormal copper metabolism.
|
CCDC115-CDG
MONDO:0014789
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
CHIME_syndrome
DISEASE
Differentiating mechanismCHIME syndrome (colobomas, heart defects, ichthyosiform dermatosis, mental retardation, ear anomalies) is caused by biallelic PIGL variants. PIGL encodes the de-N-acetylase that removes the acetyl group from N-acetylglucosaminyl-phosphatidylinositol, the second step of GPI anchor synthesis — an early assembly-step defect, distinct from the remodeling defects of Mabry syndrome.
|
CHIME syndrome
MONDO:0010221
|
yes | yes | yes | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
COG1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismCOG1 is a subunit of the conserved oligomeric Golgi (COG) complex controlling Golgi trafficking and enzyme localization; defects (CDG-IIg) disrupt multiple Golgi glycosylation steps simultaneously.
|
COG1-congenital disorder of glycosylation
MONDO:0012637
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
COG7-congenital disorder of glycosylation
DISEASE
Differentiating mechanismCOG7 deficiency (CDG-IIe) likewise impairs COG-complex-dependent Golgi trafficking, producing a severe multisystem combined N-/O-glycosylation defect.
|
COG7-congenital disorder of glycosylation
MONDO:0012118
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
DK1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismDOLK (dolichol kinase) generates dolichol phosphate, the lipid carrier for glycosylation; deficiency (CDG-Im) impairs the supply of the carrier itself, with a characteristic dilated cardiomyopathy.
|
DK1-congenital disorder of glycosylation
MONDO:0012556
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
DPM2-congenital disorder of glycosylation
DISEASE
Differentiating mechanismDPM2 is a regulatory subunit of the dolichol-phosphate-mannose synthase complex; deficiency (CDG-Iu) limits synthesis of the Dol-P-Man donor itself, upstream of the MPDU1 donor-utilization defect and affecting N-glycosylation, O-mannosylation, and GPI-anchor biosynthesis together.
|
DPM2-congenital disorder of glycosylation
MONDO:0014023
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
Larsen-like Syndrome B3GAT3 Type
DISEASE
Differentiating mechanismThe glycosaminoglycan linker tetrasaccharide. B3GAT3 adds the terminal glucuronic acid of the common GlcA-Gal-Gal-Xyl linker, so both heparan and chondroitin sulfate chains fail at once — the linkeropathy pattern of joint dislocation, short stature and congenital heart defect.
|
Larsen-like syndrome, B3GAT3 type
MONDO:0009511
|
yes | yes | yes | nested via Disorders of O-linked Protein Glycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
MGAT2-congenital disorder of glycosylation
DISEASE
Differentiating mechanismMGAT2 adds the second antenna to complex N-glycans in the Golgi; its loss (CDG-IIa) is a glycan-processing (type II) defect, contrasting with the type I LLO-assembly defects.
|
MGAT2-congenital disorder of glycosylation
MONDO:0008908
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
MOGS-Congenital Disorder of Glycosylation
DISEASE
Differentiating mechanismER glucosidase I (MOGS/GCS1), the first trimming step after the lipid-linked oligosaccharide is transferred to protein. Unusually among type II CDG it is a trimming rather than an elongation defect, and the retained Glc3Man9 precursor produces a hypogammaglobulinemia with a paradoxical resistance to enveloped-virus infection rather than the group's usual neurologic picture.
|
MOGS-congenital disorder of glycosylation
MONDO:0011629
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
MPDU1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismMPDU1 is required for utilization of dolichol-phosphate-mannose and -glucose donors; its loss (CDG-If) starves multiple LLO-assembly steps of activated sugars — a donor-utilization defect.
|
MPDU1-congenital disorder of glycosylation
MONDO:0012211
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
MPI-congenital disorder of glycosylation
DISEASE
Differentiating mechanismMPI (mannose-6-phosphate isomerase) interconverts fructose-6-phosphate and mannose-6-phosphate; deficiency (CDG-Ib) starves the GDP-mannose precursor pool rather than disabling a glycosyltransferase, which is why it is the treatable CDG - oral D-mannose bypasses the block.
|
MPI-congenital disorder of glycosylation
MONDO:0011257
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
Mabry Syndrome
DISEASE
Differentiating mechanismMabry syndrome (hyperphosphatasia with mental retardation syndrome, HPMRS) is caused by biallelic defects in the mannosyltransferase/ethanolamine-phosphate-transferase steps of GPI assembly (PIGV, PIGO) and in the post-attachment fatty-acid remodeling steps (PGAP2, PGAP3). In both the assembly-step (PIGV/PIGO) and remodeling-step (PGAP2/PGAP3) defects the GPI-anchored alkaline phosphatase is shed into serum instead of being retained at the cell surface, producing the characteristic hyperphosphatasia that distinguishes this arm of the group.
|
Mabry syndrome
MONDO:0016596
|
yes | yes | yes | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
PGM1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismPGM1 interconverts glucose-1-phosphate and glucose-6-phosphate, linking glycogen metabolism to UDP-glucose/UDP-galactose supply; deficiency is a mixed type I/type II CDG (both truncated LLO and undergalactosylated complex glycans) and the only member with a glycogenosis phenotype alongside its glycosylation defect, partially correctable with oral D-galactose.
|
PGM1-congenital disorder of glycosylation
MONDO:0013968
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
PMM2-Congenital Disorder of Glycosylation
DISEASE
Differentiating mechanismPhosphomannomutase 2 interconverts mannose-6-phosphate and mannose-1-phosphate, the step that feeds GDP-mannose into the whole lipid-linked oligosaccharide assembly line. Its deficiency (CDG-Ia) is therefore upstream of every mannosyltransferase defect in this grouping: ALG1, ALG3, ALG9 and ALG12 each lose one step, while PMM2 loss starves all of them of donor. It sits alongside MPI and PGM1 as a precursor-supply defect rather than an assembly defect, and MPI is its instructive counterpart — the adjacent step in the same supply line, but treatable with oral mannose where PMM2-CDG is not.
PMM2-CDG is also the reference case for the group clinically. It is the commonest CDG by a wide margin and the one whose phenotype the others are described against, and it is where the group's genetic architecture is clearest: complete loss of activity is not compatible with survival, so patients are hypomorph compound heterozygotes and per-allele residual activity sets severity.
|
PMM2-congenital disorder of glycosylation
MONDO:0008907
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
Peters plus syndrome
DISEASE
Differentiating mechanismO-glucosylation of thrombospondin type-1 repeats. B3GLCT extends the O-fucose on a correctly folded TSR with glucose, so the client set is the TSR-containing ADAMTS and ADAMTSL secreted proteins rather than a membrane glycoprotein, and the disease is an anterior-segment dysgenesis with skeletal features.
|
Peters plus syndrome
MONDO:0009856
|
yes | yes | yes | nested via Disorders of O-linked Protein Glycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
SLC35A2-congenital disorder of glycosylation
DISEASE
Differentiating mechanismSLC35A2 is the X-linked Golgi UDP-galactose transporter; deficiency is a nucleotide-sugar transport defect (type II) producing hypogalactosylated glycans, and is distinctive in the group for its somatic mosaic brain-limited form causing MOGHE-type refractory epilepsy.
|
SLC35A2-congenital disorder of glycosylation
MONDO:0010478
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
UGGT1-congenital disorder of glycosylation
DISEASE
Differentiating mechanismUGGT1 variants impair reglucosylation and ER retention of the UDP-glucose:glycoprotein glucosyltransferase quality-control enzyme for N-linked glycoproteins.
|
UGGT1-congenital disorder of glycosylation
MONDO:0980705
|
yes | yes | yes | nested via Other Disorders of Multiple Glycosylation Pathways | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
DHRSX-Congenital Disorder of Glycosylation
DISEASE
Differentiating mechanismDHRSX-CDG (CDG1DD) is a type I CDG upstream of LLO assembly: the defect is in dolichol synthesis itself rather than in transferring sugars onto it. DHRSX performs the first and third steps of the three-step conversion of polyprenol to dolichol, with SRD5A3 catalysing only the second, so its loss raises the polyprenol-to-dolichol ratio and starves every downstream dolichol-dependent step at once. It is also the only member with pseudoautosomal-recessive inheritance, since DHRSX lies in PAR1 of the X and Y chromosomes.
|
congenital disorder of glycosylation, type 1DD
MONDO:0975846
|
yes | yes | yes | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested in scope |
Seizures-scoliosis-macrocephaly syndrome
DISEASE
Differentiating mechanismHeparan sulfate chain polymerization. Biallelic hypomorphic EXT2 shortens the chain rather than initiating it, and is a distinct disease from the heterozygous EXT2 loss that causes hereditary multiple exostoses — the same gene, a different dose and a different phenotype.
|
seizures-scoliosis-macrocephaly syndrome
MONDO:0014731
|
yes | yes | yes | nested via Disorders of O-linked Protein Glycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| candidate in scope |
CAMLG-CDG
DISEASE
|
CAMLG-CDG
MONDO:0859357
|
yes | yes | yes | candidate | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| candidate in scope |
congenital disorder of glycosylation, type IIr
MONDO:0026765
|
yes | yes | yes | candidate | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
ALG11-congenital disorder of glycosylation
MONDO:0013349
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
ALG2-congenital disorder of glycosylation
MONDO:0011933
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
ALG6-congenital disorder of glycosylation 1C
MONDO:0011291
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
COG4-congenital disorder of glycosylation
MONDO:0013281
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
COG8-congenital disorder of glycosylation
MONDO:0012635
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
DPAGT1-congenital disorder of glycosylation
MONDO:0011964
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
Dowling-Degos Disease
DISEASE
|
Dowling-Degos disease
MONDO:0008371
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
Ehlers-Danlos syndrome, musculocontractural type
MONDO:0011142
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
GM3 synthase deficiency
DISEASE
|
GM3 synthase deficiency
MONDO:0018274
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
GNE Myopathy
DISEASE
|
GNE myopathy
MONDO:0011603
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
RFT1-congenital disorder of glycosylation
MONDO:0012783
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
SLC35A1-congenital disorder of glycosylation
MONDO:0011342
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
SRD5A3-congenital disorder of glycosylation
MONDO:0012885
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
SSR4-congenital disorder of glycosylation
MONDO:0010490
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
STT3A-congenital disorder of glycosylation
MONDO:0014270
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
TMEM165-congenital disorder of glycosylation
MONDO:0013870
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
TMEM199-CDG
DISEASE
|
TMEM199-CDG
MONDO:0014790
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
autism spectrum disorder - epilepsy - arthrogryposis syndrome
MONDO:0014248
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
congenital disorder of glycosylation, type 2v
MONDO:0030423
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
congenital disorder of glycosylation, type ICC
MONDO:0026729
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
congenital disorder of glycosylation, type IIbb
MONDO:0957820
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
congenital disorder of glycosylation, type IIw
MONDO:0030437
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
congenital disorder of glycosylation, type iit
MONDO:0030043
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
congenital myasthenic syndrome 15
MONDO:0014542
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
developmental and epileptic encephalopathy, 50
MONDO:0014647
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
leukocyte adhesion deficiency type II
MONDO:0009953
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
temtamy preaxial brachydactyly syndrome
MONDO:0011533
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | |
| MONDO gap | No DisMech entry |
A4GALT-congenital disorder of glycosylation
MONDO:0100587
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
ALG10-congenital disorder of glycosylation
MONDO:0100589
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
ALG14-congenital disorder of glycosylation
MONDO:0100559
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
ALG8-congenital disorder of glycosylation
MONDO:0011969
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
Al-Gazali syndrome
MONDO:0012282
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
B3GALT6-congenital disorder of glycosylation
MONDO:0100586
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
COG5-congenital disorder of glycosylation
MONDO:0013325
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
COG6-congenital disorder of glycosylation
MONDO:0013810
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
DDOST-congenital disorder of glycosylation
MONDO:0013789
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
DPM3-congenital disorder of glycosylation
MONDO:0013049
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
Ehlers-Danlos syndrome, spondylodysplastic type, 2
MONDO:0014139
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
FAM20B-congenital disorder of glycosylation
MONDO:0100588
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
MAN1B1-congenital disorder of glycosylation
MONDO:0018349
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
Reunion island Larsen syndrome
MONDO:0017413
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
SLC10A7-congenital disorder of glycosylation
MONDO:0100068
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
SLC39A8-CDG
MONDO:0014746
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
SSR3-CDG
MONDO:0300000
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
ST3GAL3-congenital disorder of glycosylation
MONDO:0979317
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
STT3B-congenital disorder of glycosylation
MONDO:0014271
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
XYLT1-congenital disorder of glycosylation
MONDO:0018273
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2I
MONDO:0011787
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2K
MONDO:0012248
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2M
MONDO:0012699
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2N
MONDO:0013162
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2O
MONDO:0013161
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2P
MONDO:0013440
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2R1
MONDO:0014977
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2T
MONDO:0014142
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive limb-girdle muscular dystrophy type 2U
MONDO:0014474
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
autosomal recessive spondylocostal dysostosis
MONDO:0010180
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation syndrome type 4
MONDO:0022622
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation type 1E
MONDO:0012123
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation type 1EE with or without immunodeficiency
MONDO:0976261
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation type I
MONDO:0005500
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation type II
MONDO:0005501
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation with defective fucosylation
MONDO:0060720
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation with defective fucosylation 1
MONDO:0020775
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation with defective fucosylation 2
MONDO:0020777
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation, type IAA
MONDO:0014904
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation, type IIaa
MONDO:0957540
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation, type IIq
MONDO:0054559
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation, type IIy
MONDO:0859356
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation, type Ibb
MONDO:0800353
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital disorder of glycosylation, type Iw, autosomal dominant
MONDO:0859223
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital dyserythropoietic anemia type 2
MONDO:0009134
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital muscular dystrophy caused by variation in POMGNT2
MONDO:0700075
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
congenital muscular dystrophy with intellectual disability
MONDO:0018278
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
defect in V-ATPase
MONDO:0017752
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
defect in conserved oligomeric Golgi complex
MONDO:0017750
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
developmental and epileptic encephalopathy, 15
MONDO:0014003
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
developmental and epileptic encephalopathy, 36
MONDO:0010472
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
disorder of fucoglycosan synthesis
MONDO:0017747
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
disorder of multiple glycosylation
MONDO:0017749
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
disorder of protein N-glycosylation
MONDO:0017740
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
disorder of protein O-glycosylation
MONDO:0017741
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency
MONDO:0012465
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
immunodeficiency 23
MONDO:0014353
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation
MONDO:0017748
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies
MONDO:0033572
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
intellectual disability, autosomal recessive 12
MONDO:0012612
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
intellectual disability, autosomal recessive 53
MONDO:0014832
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
limb-girdle muscular dystrophy due to POMK deficiency
MONDO:0014489
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
multiple congenital anomalies-hypotonia-seizures syndrome 1
MONDO:0013563
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
multiple congenital anomalies-hypotonia-seizures syndrome 2
MONDO:0010466
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
multiple congenital anomalies-hypotonia-seizures syndrome 3
MONDO:0014165
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4
MONDO:0009678
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
MONDO:0013835
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
MONDO:0009364
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14
MONDO:0014140
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
MONDO:0013154
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
MONDO:0009667
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
MONDO:0013157
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
MONDO:0013904
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15
MONDO:0033556
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
MONDO:0013159
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14
MONDO:0014141
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
MONDO:0013160
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3
MONDO:0013155
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4
MONDO:0013156
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8
MONDO:0029135
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
muscular dystrophy-dystroglycanopathy type B5
MONDO:0011688
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in CRPPA
MONDO:0100530
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in FKRP
MONDO:0700066
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in FKTN
MONDO:0700067
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in GMPPB
MONDO:0700084
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in POMGNT1
MONDO:0700068
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in POMGNT2
MONDO:0700069
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in POMT1
MONDO:0700070
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy caused by variation in POMT2
MONDO:0700071
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
myopathy, epilepsy, and progressive cerebral atrophy
MONDO:0033619
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
progressive myoclonic epilepsy type 3
MONDO:0012721
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
qualitative or quantitative defects of FKRP
MONDO:0016156
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
qualitative or quantitative defects of protein O-mannosyltransferase 1
MONDO:0016184
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
qualitative or quantitative defects of protein O-mannosyltransferase 2
MONDO:0016185
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan
MONDO:0016155
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
spondylocostal dysostosis 1, autosomal recessive
MONDO:0020692
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
spondylocostal dysostosis 2, autosomal recessive
MONDO:0012097
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
spondylocostal dysostosis 3, autosomal recessive
MONDO:0012349
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
spondylocostal dysostosis 4, autosomal recessive
MONDO:0013366
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
spondylocostal dysostosis 6, autosomal recessive
MONDO:0014694
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures
MONDO:0010075
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Autosomal Recessive Cutis Laxa Type 2A
DISEASE
Differentiating mechanismATP6V0A2, the Golgi V-ATPase a2 subunit. The lesion is Golgi luminal acidification, not a transferase or a nucleotide-sugar pool, and it disables N- and O-linked glycosylation together — which is what places it here rather than in a branch-specific sibling. The distinguishing consequence is defective elastic-fibre assembly, giving cutis laxa beside the neuronal migration defect.
|
ATP6V0A2-related cutis laxa
MONDO:0018163
|
yes | yes | no | nested via Other Disorders of Multiple Glycosylation Pathways | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Paroxysmal Nocturnal Hemoglobinuria
DISEASE
Differentiating mechanismParoxysmal nocturnal hemoglobinuria is the ACQUIRED member: a somatic PIGA mutation in a hematopoietic stem cell abolishes the committed first step of GPI anchor synthesis (transfer of GlcNAc to phosphatidylinositol). The resulting loss of GPI-anchored complement regulators CD55 and CD59 on the clonal red cells causes complement-mediated intravascular hemolysis. Unlike the germline members it is X-linked-somatic and clonal, not inherited, and its phenotype is hematologic rather than a developmental encephalopathy.
|
Paroxysmal Nocturnal Hemoglobinuria
MONDO:0100244
|
yes | yes | no | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| candidate outside grouping MONDO |
Spondylo-ocular Syndrome
DISEASE
|
Spondylo-ocular Syndrome
MONDO:0011604
|
yes | yes | no | candidate | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
VPS51-Related Pontocerebellar Hypoplasia-CDG
DISEASE
Differentiating mechanismVPS51 is the shared subunit of the GARP and EARP endosomal tethering complexes; deficiency impairs endosome-to-trans-Golgi retrograde traffic and therefore Golgi glycosylation-enzyme positioning - the same class of trafficking lesion as the COG disorders but at a distinct tether.
|
VPS51-related pontocerebellar hypoplasia-CDG
MONDO:0032831
|
yes | yes | no | nested via Congenital Disorders of Glycosylation | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
NGLY1-congenital disorder of deglycosylation
DISEASE
Differentiating mechanismNGLY1 encodes cytosolic N-glycanase 1; deficiency blocks removal of N-glycans from misfolded glycoproteins retrotranslocated for ERAD and proteasomal degradation.
|
congenital disorder of deglycosylation 1
MONDO:0800044
|
yes | yes | no | nested via Congenital Disorders of Deglycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
MAN2C1-congenital disorder of deglycosylation 2
DISEASE
Differentiating mechanismMAN2C1 encodes a cytosolic alpha-mannosidase; deficiency delays trimming and catabolism of free oligosaccharides, causing their accumulation in patient-derived cells.
|
congenital disorder of deglycosylation 2
MONDO:0030770
|
yes | yes | no | nested via Congenital Disorders of Deglycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Developmental And Epileptic Encephalopathy 38
DISEASE
Differentiating mechanismDEE38 is the ARV1 arm of inherited GPI deficiency. ARV1 is not a PIG/PGAP biosynthetic enzyme but a facilitating component of the GPI-GnT complex that initiates GPI-anchor assembly (it associates with PIGQ and promotes recruitment of the phosphatidylinositol substrate), so ARV1 loss reduces GPI-anchor synthesis at its very first, committed step. Patient neutrophils and fibroblasts show reduced surface GPI-anchored proteins, placing DEE38 among the inherited GPI-deficiency disorders; the phenotype is an autosomal-recessive developmental and epileptic encephalopathy with progressive cerebral and cerebellar atrophy, without the hyperphosphatasia of the Mabry/HPMRS arm. Its membership rests on the NECESSARY GO:0180046 criterion rather than on MONDO ancestry — MONDO does not yet classify MONDO:0014868 under disorder of GPI anchor biosynthesis.
|
developmental and epileptic encephalopathy, 38
MONDO:0014868
|
yes | yes | no | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Developmental and Epileptic Encephalopathy 55
DISEASE
Differentiating mechanismPIGP, a subunit of the GPI-GlcNAc transferase complex that catalyses the committed first step of GPI assembly — the same step PIGA serves, but reached through an autosomal recessive subunit rather than the X-linked catalytic one, so the phenotype is a developmental and epileptic encephalopathy rather than the somatic-clone haemolytic disease of PIGA.
|
developmental and epileptic encephalopathy, 55
MONDO:0033364
|
yes | yes | no | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Developmental And Epileptic Encephalopathy 77
DISEASE
Differentiating mechanismDEE77 (PIGQ-CDG, MCAHS4, GPIBD19) is the PIGQ arm of inherited GPI deficiency. PIGQ is a component of the GPI-N-acetylglucosaminyltransferase complex that performs the first committed step of the pathway — transfer of GlcNAc from UDP-GlcNAc onto phosphatidylinositol on the cytoplasmic face of the ER — so the lesion sits alongside PIGA, PIGC, PIGH, PIGP and PIGY rather than at the mannosyltransferase or remodelling steps. Patient granulocytes, leukocytes and fibroblasts show reduced surface GPI-anchored proteins, restored by wild-type PIGQ cDNA. The phenotype is a severe autosomal recessive developmental and epileptic encephalopathy with multiple congenital anomalies, high childhood mortality (median survival 5.5 years across the 13 published patients), and a consistent craniofacial gestalt. It differs from the other first-step members curated here in one respect worth flagging: elevated serum alkaline phosphatase is reported in 62% of PIGQ patients, which the pathway-position account of hyperphosphatasia — a Mabry/HPMRS feature arising from mannose-bearing incomplete anchors — does not predict for a block this early. That tension is recorded as a knowledge gap on the disease entry rather than resolved here.
|
developmental and epileptic encephalopathy, 77
MONDO:0032808
|
yes | yes | no | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
UGP2-related developmental and epileptic encephalopathy 83
DISEASE
Differentiating mechanismUGP2 short-isoform loss in brain reduces UDP-glucose production in neural stem cells, affecting glycogen metabolism, glycosylation, and ER proteostasis.
|
developmental and epileptic encephalopathy, 83
MONDO:0032895
|
yes | yes | no | nested via Other Disorders of Multiple Glycosylation Pathways | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
UGDH-related developmental and epileptic encephalopathy 84
DISEASE
Differentiating mechanismUGDH loss reduces conversion of UDP-glucose to UDP-glucuronic acid, limiting precursor supply for glycosaminoglycan-rich proteoglycans and glycolipids.
|
developmental and epileptic encephalopathy, 84
MONDO:0032918
|
yes | yes | no | nested via Other Disorders of Multiple Glycosylation Pathways | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Dystroglycanopathy
DISEASE
Differentiating mechanismO-mannosylation of alpha-dystroglycan. The matriglycan that binds laminin is built on an O-mannose, so the whole gene series (POMT1, POMT2, POMGNT1/2, POMK, B3GALNT2, B4GAT1, RXYLT1, FKTN, FKRP, LARGE1, CRPPA) converges on loss of laminin binding at the muscle and pial basement membrane.
|
dystroglycanopathy
MONDO:0018276
|
yes | yes | no | nested via Disorders of O-linked Protein Glycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Glycosylphosphatidylinositol Biosynthesis Defect 15
DISEASE
Differentiating mechanismGPIBD15 is the GPAA1 arm of inherited GPI deficiency and the only member here whose lesion is in the GPI transamidase, the five-subunit complex (PIGK, GPAA1, PIGS, PIGT, PIGU) that attaches the completed anchor to precursor proteins. The anchor is made but not transferred, so surface GPI-anchored proteins fall while serum alkaline phosphatase stays normal or low rather than raised, unlike the Mabry/HPMRS arm. Patients have developmental delay, hypotonia, early-onset often drug-resistant epilepsy, acquired cerebellar atrophy and osteopenia. It meets the NECESSARY criterion through attachment of GPI anchor to protein (GO:0016255), a component process of GPI anchored protein biosynthesis.
|
glycosylphosphatidylinositol biosynthesis defect 15
MONDO:0060627
|
yes | yes | no | nested via Disorders of GPI Anchor Biosynthesis | contradiction | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Immunoskeletal Dysplasia with Neurodevelopmental Abnormalities
DISEASE
Differentiating mechanismHeparan sulfate chain initiation. EXTL3 transfers the first GlcNAc onto the completed linker, committing the chain to heparan sulfate, which is why the phenotype adds T-cell immunodeficiency and neurodevelopmental involvement to the skeletal dysplasia rather than reproducing the linkeropathy.
|
immunoskeletal dysplasia with neurodevelopmental abnormalities
MONDO:0044312
|
yes | yes | no | nested via Disorders of O-linked Protein Glycosylation | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome
DISEASE
Differentiating mechanismMCAHS is the severe developmental-and-epileptic-encephalopathy arm of germline inherited GPI deficiency, an umbrella over three subtypes defined by the affected GPI-pathway gene: MCAHS1 (PIGN, ethanolamine-phosphate transfer), MCAHS2 (PIGA, the committed first GlcNAc-transfer step; X-linked and mechanistically distinct from the somatic-PIGA clone of PNH), and MCAHS3 (PIGT, GPI transamidase attachment). Unlike the Mabry/HPMRS arm, MCAHS does not show persistent hyperphosphatasia (serum alkaline phosphatase is normal, or low in PIGT/MCAHS3), and the clinical picture is dominated by multiple congenital anomalies and early-onset drug-resistant epileptic encephalopathy rather than the bone-enzyme abnormality.
|
multiple congenital anomalies-hypotonia-seizures syndrome
MONDO:0100247
|
yes | yes | no | nested via Disorders of GPI Anchor Biosynthesis | satisfied | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| nested outside grouping MONDO |
Short Stature, Amelogenesis Imperfecta, and Skeletal Dysplasia with Scoliosis
DISEASE
Differentiating mechanismSLC10A7, a Golgi calcium-handling transporter. Like the ATP6V0A2 member the proximal lesion is a Golgi luminal condition rather than a glycosylation enzyme, but the perturbed variable is calcium rather than pH, and the client range extends to glycosaminoglycan synthesis as well as N- and O-glycans — hence a skeletal dysplasia with amelogenesis imperfecta.
|
short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis
MONDO:0032703
|
yes | yes | no | nested via Other Disorders of Multiple Glycosylation Pathways | satisfied | SATISFIED | SATISFIED | NOT SATISFIED | SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech only |
Congenital Disorders of Deglycosylation
GROUPING
Differentiating mechanismICIMD 18, other disorders of glycan metabolism — the direction-reversed arm. Where the other three children fail to attach a glycan, these fail to remove and clear one: cytosolic peptide:N-glycanase (NGLY1) releasing the N-glycan from a retrotranslocated misfolded glycoprotein, and cytosolic alpha-mannosidase (MAN2C1) trimming the free oligosaccharide that release generates. The conforming module is cytosolic_deglycosylation, not congenital_disorder_of_glycosylation.
|
No MONDO identity | yes | no | no MONDO ID | listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech only |
Congenital Disorders of Glycosylation
GROUPING
Differentiating mechanismICIMD 18, N-linked protein glycosylation. Defects in the assembly of the dolichol-linked oligosaccharide precursor, its transfer to nascent protein, or its Golgi remodeling, together with the nucleotide-sugar and dolichol supply lines feeding them (ALG1/3/9/12, DPM2, MPDU1, DOLK, PMM2, MPI, PGM1, MGAT2, SLC35A2, COG1, COG7, VPS51, DHRSX), plus ER glucosidase-I trimming (MOGS), terminal antenna galactosylation (B4GALT1), and Golgi V-ATPase assembly (CCDC115). The diagnostic readout is the serum transferrin glycoform profile, type I versus type II.
|
No MONDO identity | yes | no | no MONDO ID | listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech only |
Disorders of GPI Anchor Biosynthesis
GROUPING
Differentiating mechanismICIMD 18, lipid glycosylation. Defects in assembly, transfer, or post-attachment remodeling of the glycosylphosphatidylinositol anchor, so the affected clients are the GPI-anchored surface proteins rather than the N-glycoproteins (PIGA, PIGL, PIGP, PIGV, PIGO, PGAP2, PGAP3). Hyperphosphatasia from unanchored alkaline phosphatase, and — for the somatic PIGA case, paroxysmal nocturnal hemoglobinuria — complement-mediated hemolysis from lost CD55/CD59, are the distinguishing readouts.
|
No MONDO identity | yes | no | no MONDO ID | listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech only |
Disorders of O-linked Protein Glycosylation
GROUPING
Differentiating mechanismICIMD 18, O-linked protein glycosylation, including glycosaminoglycan synthesis. Defects in a glycan attached to a serine or threonine hydroxyl rather than an asparagine amide, divided by first sugar: O-mannose on alpha-dystroglycan (the dystroglycanopathy gene series), O-glucose on thrombospondin type-1 repeats (B3GLCT), and the O-xylose linker that starts every glycosaminoglycan chain (B3GAT3, EXTL3, EXT2). Distinguished from the N-glycan child by linkage chemistry and client protein family, and from the multiple-pathway child by the lesion being confined to this branch.
|
No MONDO identity | yes | no | no MONDO ID | listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
| DisMech only |
Other Disorders of Multiple Glycosylation Pathways
GROUPING
Differentiating mechanismICIMD 18, disorders affecting multiple glycosylation pathways. Lesions upstream of, or lateral to, any single branch: UDP-sugar precursor supply serving glycosaminoglycan, glycolipid, and protein glycosylation at once (UGDH, UGP2), and ER re-glucosylation quality control of N-glycoproteins (UGGT1), and Golgi luminal conditions that disable several branches at once — pH via the V-ATPase a2 subunit (ATP6V0A2) and calcium handling (SLC10A7). Distinguished from the N-glycan child by the lesion not being specific to one glycosylation branch.
|
No MONDO identity | yes | no | no MONDO ID | listed | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated | not evaluated |
Source
View YAML on GitHubRaw YAML
name: Disorders of Protein and Lipid Glycosylation
display_name: Disorders of Protein and Lipid Glycosylation (ICIMD category 18)
creation_date: "2026-09-17T00:00:00Z"
description: >-
The umbrella union of inherited disorders in which the lesion is in the
attachment, remodeling, or removal of a glycan on a protein or a lipid. Glycans
are added to most secreted and membrane proteins and to a large class of lipids;
a defect anywhere in that machinery — precursor supply, transfer to the acceptor,
Golgi maturation, or the cytosolic clearance of released glycans — hypoglycosylates
many client molecules at once, which is why the resulting diseases are
characteristically multisystem. This grouping points down to five nested
sub-groupings drawn on the branch of the glycosylation machinery that fails:
protein N-glycosylation, protein O-glycosylation (including the
glycosaminoglycan chains built on an O-xylose), GPI-anchor (lipid)
glycosylation, precursor-supply and ER-quality-control lesions that hit
several branches at once, and cytosolic deglycosylation.
grouping_basis:
- SHARED_MECHANISM
- CLINICAL_CONVENTION
grouping_rationale: >-
Grouped on the shared mechanism family — a lesion in glycoconjugate metabolism,
with hypoglycosylation (or, for the deglycosylation arm, failure to clear a
released glycan) as the common intermediate lesion — and on an established
nosological convention: category 18 of the International Classification of
Inherited Metabolic Disorders (ICIMD; Ferreira et al. 2021, PMID:33340416),
whose own subdivision into N-linked, O-linked, lipid, and multiple-pathway
glycosylation disorders is what the nested sub-groupings mirror.
This grouping points down to nested sub-groupings rather than listing
member diseases flatly, following the pattern of Inborn_Errors_of_Immunity over
the IUIS tables. It adds no direct disease members of its own. Each child keeps
its own, narrower NECESSARY criterion; this parent's criterion is the
disjunction of theirs, so any disease that satisfies its own sub-grouping
necessarily satisfies this one.
Why this exists rather than being folded into the existing
Congenital_Disorders_of_Glycosylation grouping. That grouping is deliberately
scoped to protein N-glycosylation and its precursor and trafficking supply
lines — a boundary its own rationale states and defends — while binding
MONDO:0015286 (congenital disorder of glycosylation), which is the broader
concept covering O-linked, GPI-anchor, and glycosphingolipid defects as well.
A grouping cannot both be deliberately narrower than a concept and exactMatch
it. Creating the umbrella resolves that: the exactMatch to MONDO:0015286 moves
here, and the N-glycan grouping is downgraded to skos:narrowMatch, which still
counts as curated for MONDO coverage.
Naming. ICIMD titles category 18 "Congenital disorders of glycosylation", but
that name is already taken in kb/groupings/ by the N-glycan-scoped child and
grouping names are foreign-key targets, so renaming it would break existing
references and history records. This grouping therefore takes a descriptive
name; "ICIMD category 18" is carried in display_name so the correspondence is
not lost.
Boundary — two exclusions worth recording, because both are things a reader
would expect to find here. Glycogen storage diseases are out: glycogen is a
storage homopolysaccharide, not a glycoconjugate, and ICIMD places disorders of
glycogen metabolism outside the glycan-metabolism categories explicitly. The
mucopolysaccharidoses are also out: they are lysosomal catabolism of
glycosaminoglycans, already held by Mucopolysaccharidoses beneath
Lysosomal_Storage_Disorders, and ICIMD places glycosaminoglycan *synthesis*
under O-linked protein glycosylation rather than placing GAG degradation in
category 18. Both are glycobiology in the loose sense; neither is a defect of
glycan attachment to a protein or lipid.
mappings:
mondo_mappings:
- term:
id: MONDO:0015286
label: congenital disorder of glycosylation
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: >-
MONDO:0015286 is the broad congenital-disorder-of-glycosylation class,
spanning N-linked, O-linked, GPI-anchor, and glycosphingolipid defects.
That is this grouping's concept, not the narrower N-glycan concept of the
nested Congenital_Disorders_of_Glycosylation child, which now carries
skos:narrowMatch against the same term. MONDO descendants without DisMech
entries are curation gaps rather than a reason to downgrade the predicate.
consistency:
- reference: MONDO
consistent: INCONSISTENT
notes: >-
Re-derived 2026-09-18 over all 38 transitively held members: 24 are
hierarchical descendants of MONDO:0015286 and 14 are not. Recorded as
INCONSISTENT because that is what was measured; the mapping predicate is
deliberately left at skos:exactMatch pending a decision, and this note is
the evidence for that decision rather than a pre-emption of it.
Method, reproducible without a local MONDO build: each member's own MONDO
term is resolved to its ancestor set via the OLS hierarchicalAncestors
endpoint and MONDO:0015286 looked up in it — one bounded upward walk per
member (13-38 terms) instead of one unbounded downward expansion of the
class. The OAK ols:mondo adapter raises NotImplementedError for both
directions, but the REST endpoint underneath answers ancestors.
The 14 divide into two kinds, and only one is a defect. (1) Genuine scope
difference: MONDO scopes congenital disorder of glycosylation narrower
than ICIMD category 18 does. The two deglycosylation members sit under
MONDO:0031376 congenital disorder of deglycosylation, a *sibling* of
MONDO:0015286 beneath MONDO:0019052 inborn errors of metabolism, and five
of the six GPI-anchor members are likewise outside the class. ICIMD puts
both inside category 18; MONDO does not. (2) Classification by clinical
presentation rather than mechanism: Dystroglycanopathy sits under
muscular dystrophy, Autosomal Recessive Cutis Laxa Type 2A under cutis
laxa and hereditary skin disorder (verified against its direct parents,
which carry no CDG term), the SLC10A7 and EXTL3 entries under skeletal
system disorder, the PIG-gene entries under the epilepsies, and
VPS51-CDG under pontocerebellar hypoplasia. These are candidate MONDO
term requests, not membership errors.
What this means for the predicate: the umbrella's concept properly
*contains* the MONDO class rather than equalling it, which is
skos:broadMatch and not skos:exactMatch. The reason it has not simply
been flipped is that the change is not free — per CLAUDE.md a broadMatch
does not count as curated for MONDO coverage, and
scripts/grouping_mondo_gaps.py derives descendant gaps only from an
exactMatch, so flipping it here after the N-glycan child was downgraded
to narrowMatch would leave MONDO:0015286 with no exactMatch anywhere in
the family and silently end gap derivation for the whole CDG branch.
Semantics and tooling disagree; that is a design call for the decision
register, not a predicate to change twice in two days.
membership_criteria:
- description: >-
A member is an inherited disorder whose proximal lesion is in the
biosynthesis, transfer, remodeling, or removal of a glycan attached to a
protein or a lipid — including the nucleotide-sugar and dolichol precursor
supply feeding those steps, the Golgi machinery that matures the glycan, and
the cytosolic enzymes that clear a released glycan. Disorders of glycogen
metabolism and of lysosomal glycosaminoglycan catabolism are excluded.
criteria_semantics: NECESSARY
logic:
operator: OR
description: >-
The disjunction of the five nested sub-groupings' own NECESSARY criteria.
Stated as a union rather than as a single broader process term because no
one GO class subsumes protein glycosylation, GPI-anchor (lipid)
glycosylation, and protein deglycosylation; a member satisfies this parent
through whichever branch its own sub-grouping already requires.
operands:
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves protein N-linked glycosylation (assembly/transfer) — the
Congenital_Disorders_of_Glycosylation branch.
biological_processes:
- preferred_term: protein N-linked glycosylation
term:
id: GO:0006487
label: protein N-linked glycosylation
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves N-glycan processing (Golgi maturation) — the
Congenital_Disorders_of_Glycosylation branch.
biological_processes:
- preferred_term: N-glycan processing
term:
id: GO:0006491
label: N-glycan processing
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves GPI anchor biosynthesis — the
Disorders_of_GPI_Anchor_Biosynthesis branch, ICIMD's lipid-glycosylation
subdivision.
biological_processes:
- preferred_term: GPI anchor biosynthetic process
term:
id: GO:0006506
label: GPI anchor biosynthetic process
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves glycoprotein biosynthesis without the lesion being specific to
a named branch — the Other_Multiple_Glycosylation_Pathway_Disorders
branch, whose members are there precisely because their lesion spans
several. Ontology closure makes this subsume the two N-linked and the
O-linked operands, which are kept so a member's own branch stays
readable off the criterion that matched it.
biological_processes:
- preferred_term: protein glycosylation
term:
id: GO:0009101
label: glycoprotein biosynthetic process
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves protein O-linked glycosylation — the
Disorders_of_O-linked_Protein_Glycosylation branch (O-mannose,
O-glucose/O-fucose, and the O-xylose glycosaminoglycan linker). Also
satisfied by Other_Multiple_Glycosylation_Pathway_Disorders members
whose branch-non-specific lesion reaches O-glycans.
biological_processes:
- preferred_term: protein O-linked glycosylation
term:
id: GO:0006493
label: protein O-linked glycosylation
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves glycosaminoglycan biosynthesis — the GAG-*synthesis* arm that
ICIMD places under O-linked protein glycosylation. Note this is
biosynthesis, not the lysosomal catabolism of the mucopolysaccharidoses.
biological_processes:
- preferred_term: glycosaminoglycan biosynthetic process
term:
id: GO:0006024
label: glycosaminoglycan biosynthetic process
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves ER protein folding — carried because
Other_Multiple_Glycosylation_Pathway_Disorders requires it for UGGT1,
whose lesion is re-glucosylation-based quality control of N-glycans.
biological_processes:
- preferred_term: protein folding in endoplasmic reticulum
term:
id: GO:0034975
label: protein folding in endoplasmic reticulum
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves proteoglycan biosynthesis — carried because
Disorders_of_O-linked_Protein_Glycosylation requires it for the two
members that annotate only the proteoglycan-product classes
(GO:0015012, GO:0050650) rather than the glycosaminoglycan class.
Without it this disjunction was not in fact the union of its children's
criteria, which is what the logic description above claims.
biological_processes:
- preferred_term: proteoglycan biosynthetic process
term:
id: GO:0030166
label: proteoglycan biosynthetic process
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves protein deglycosylation — the
Congenital_Disorders_of_Deglycosylation branch.
biological_processes:
- preferred_term: protein deglycosylation
term:
id: GO:0006517
label: protein deglycosylation
- criterion_predicate: HAS_BIOLOGICAL_PROCESS
description: >-
Involves oligosaccharide catabolism — the
Congenital_Disorders_of_Deglycosylation branch (free-oligosaccharide
trimming).
biological_processes:
- preferred_term: oligosaccharide catabolic process
term:
id: GO:0009313
label: oligosaccharide catabolic process
evidence:
- reference: PMID:33340416
reference_title: "An international classification of inherited metabolic disorders (ICIMD)."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The Congenital Disorders of Glycosylation (CDG) are divided into disorders
affecting N-linked and O-linked protein glycosylation (including
glycosaminoglycan synthesis), disorders of lipid glycosylation (including
the disorders of glycosylphosphatidylinositol biosynthesis), and disorders
with the potential to affect multiple glycosylation pathways (dolichol
metabolism, Golgi transport and homeostasis, sialic acid metabolism, and
others).
explanation: >-
The ICIMD category-18 subdivision this grouping's five nested children
mirror. It is also what places the GPI-anchor disorders inside the
glycosylation umbrella rather than beside it, which is the membership
decision most likely to be questioned.
- reference: PMID:33340416
reference_title: "An international classification of inherited metabolic disorders (ICIMD)."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
they include disorders of glycan metabolism (including the congenital
disorders of glycosylation but excluding disorders of glycogen metabolism)
explanation: >-
Sources the glycogen exclusion recorded in grouping_rationale: ICIMD keeps
disorders of glycogen metabolism out of the glycan-metabolism categories,
so Glycogen_Storage_Diseases is correctly not a child here.
- description: >-
An entry assigned to ICIMD category 18 — congenital disorders of
glycosylation, or any of its N-linked, O-linked, lipid, multiple-pathway, or
other-glycan-metabolism subdivisions — via classifications.icimd_category
belongs in this grouping.
criteria_semantics: SUFFICIENT
logic:
operator: OR
description: >-
A discovery criterion, not an audit of the listed members: it is stated
SUFFICIENT so that entries carrying an ICIMD category-18 value but not yet
reached by any nested sub-grouping surface as candidate additions. Those
currently outstanding are named in notes. It is deliberately not NECESSARY
— most listed members carry no icimd_category value at all, and a
NECESSARY reading would report that curation gap as a membership
contradiction.
operands:
- criterion_predicate: HAS_CLASSIFICATION
classification: "icimd_category:congenital_disorders_of_glycosylation"
description: ICIMD category 18 at the category level.
- criterion_predicate: HAS_CLASSIFICATION
classification: "icimd_category:n_linked_protein_glycosylation"
description: ICIMD 18, N-linked protein glycosylation.
- criterion_predicate: HAS_CLASSIFICATION
classification: "icimd_category:o_linked_protein_glycosylation"
description: ICIMD 18, O-linked protein glycosylation (incl. GAG synthesis).
- criterion_predicate: HAS_CLASSIFICATION
classification: "icimd_category:lipid_glycosylation"
description: ICIMD 18, lipid glycosylation (incl. GPI biosynthesis).
- criterion_predicate: HAS_CLASSIFICATION
classification: "icimd_category:multiple_glycosylation_pathways"
description: >-
ICIMD 18, disorders affecting multiple glycosylation pathways (dolichol
metabolism, Golgi transport and homeostasis, sialic acid metabolism).
- criterion_predicate: HAS_CLASSIFICATION
classification: "icimd_category:other_glycan_metabolism"
description: ICIMD 18, other disorders of glycan metabolism.
members:
- member: Congenital Disorders of Glycosylation
member_type: GROUPING
differentiating_mechanisms:
- description: >-
ICIMD 18, N-linked protein glycosylation. Defects in the assembly of the
dolichol-linked oligosaccharide precursor, its transfer to nascent protein,
or its Golgi remodeling, together with the nucleotide-sugar and dolichol
supply lines feeding them (ALG1/3/9/12, DPM2, MPDU1, DOLK, PMM2, MPI, PGM1,
MGAT2, SLC35A2, COG1, COG7, VPS51, DHRSX), plus ER glucosidase-I trimming
(MOGS), terminal antenna galactosylation (B4GALT1), and Golgi V-ATPase
assembly (CCDC115). The diagnostic readout is the
serum transferrin glycoform profile, type I versus type II.
- member: Disorders of GPI Anchor Biosynthesis
member_type: GROUPING
differentiating_mechanisms:
- description: >-
ICIMD 18, lipid glycosylation. Defects in assembly, transfer, or
post-attachment remodeling of the glycosylphosphatidylinositol anchor, so
the affected clients are the GPI-anchored surface proteins rather than the
N-glycoproteins (PIGA, PIGL, PIGP, PIGV, PIGO, PGAP2, PGAP3).
Hyperphosphatasia
from unanchored alkaline phosphatase, and — for the somatic PIGA case,
paroxysmal nocturnal hemoglobinuria — complement-mediated hemolysis from
lost CD55/CD59, are the distinguishing readouts.
- member: Disorders of O-linked Protein Glycosylation
member_type: GROUPING
differentiating_mechanisms:
- description: >-
ICIMD 18, O-linked protein glycosylation, including glycosaminoglycan
synthesis. Defects in a glycan attached to a serine or threonine hydroxyl
rather than an asparagine amide, divided by first sugar: O-mannose on
alpha-dystroglycan (the dystroglycanopathy gene series), O-glucose on
thrombospondin type-1 repeats (B3GLCT), and the O-xylose linker that starts
every glycosaminoglycan chain (B3GAT3, EXTL3, EXT2). Distinguished from the
N-glycan child by linkage chemistry and client protein family, and from the
multiple-pathway child by the lesion being confined to this branch.
- member: Other Disorders of Multiple Glycosylation Pathways
member_type: GROUPING
differentiating_mechanisms:
- description: >-
ICIMD 18, disorders affecting multiple glycosylation pathways. Lesions
upstream of, or lateral to, any single branch: UDP-sugar precursor supply
serving glycosaminoglycan, glycolipid, and protein glycosylation at once
(UGDH, UGP2), and ER re-glucosylation quality control of N-glycoproteins
(UGGT1), and Golgi luminal conditions that disable several branches at
once — pH via the V-ATPase a2 subunit (ATP6V0A2) and calcium handling
(SLC10A7). Distinguished from the N-glycan child by the lesion not being
specific to one glycosylation branch.
- member: Congenital Disorders of Deglycosylation
member_type: GROUPING
differentiating_mechanisms:
- description: >-
ICIMD 18, other disorders of glycan metabolism — the direction-reversed
arm. Where the other three children fail to attach a glycan, these fail to
remove and clear one: cytosolic peptide:N-glycanase (NGLY1) releasing the
N-glycan from a retrotranslocated misfolded glycoprotein, and cytosolic
alpha-mannosidase (MAN2C1) trimming the free oligosaccharide that release
generates. The conforming module is cytosolic_deglycosylation, not
congenital_disorder_of_glycosylation.
notes: >-
Why the umbrella was created. The four children were already behaving as
siblings without a parent: each one's grouping_rationale names the others as
the home for what it excludes. Disorders_of_GPI_Anchor_Biosynthesis excludes
DPM2-CDG and MPDU1-CDG because their Dol-P-Man lesion belongs "in the broader
glycosylation grouping"; Congenital_Disorders_of_Glycosylation names GPI,
multiple-pathway, and TSR O-fucosylation as sibling homes. That mutual
cross-referencing was the signal that a node was missing, and it means the
boundary work this grouping depends on was already done in prose.
Resolved — the O-linked child. This grouping was created holding only four of
ICIMD category 18's five subdivisions, with no member for O-linked protein
glycosylation, and said so. Disorders of O-linked Protein Glycosylation now
fills it, drawn from the five entries that already carried
classifications.icimd_category o_linked_protein_glycosylation: the
Dystroglycanopathy entry (O-mannose), Peters plus syndrome (O-glucose on
thrombospondin type-1 repeats), and the three glycosaminoglycan-synthesis
disorders ICIMD places in this subdivision rather than a separate one
(B3GAT3, EXTL3, EXT2). All five evaluate SATISFIED against its NECESSARY
criterion.
Resolved — the candidate backlog. The eleven category-18 entries that belonged
to no child are now placed, and the SUFFICIENT ICIMD criterion reports no
candidates. Beyond the five O-linked entries above: MOGS-CDG, B4GALT1-CDG and
CCDC115-CDG went to the N-glycan child, which is the same membership drift the
2026-08-20 review corrected for seven other CDG entries; Developmental and
Epileptic Encephalopathy 55 (PIGP) went to the GPI child; and Autosomal
Recessive Cutis Laxa Type 2A (ATP6V0A2, Golgi pH) and Short Stature,
Amelogenesis Imperfecta, and Skeletal Dysplasia with Scoliosis (SLC10A7, Golgi
calcium) went to the multiple-pathway child. The last two annotate protein
O-linked glycosylation and were deliberately *not* put in the O-linked child:
their lesions are Golgi luminal conditions that disable several branches at
once, and O-glycosylation being among a disorder's casualties does not make it
an O-linked disorder.
An empty candidate list is a statement about ICIMD coverage, not about
completeness. It means every entry that *carries* a category-18 classification
is now held by a child; entries whose glycosylation lesion is real but
unclassified remain invisible to that criterion. Widening coverage of
classifications.icimd_category across kb/disorders is the way to make the
report say more.
Resolved — UGP2. UGP2-related developmental and epileptic encephalopathy 83
evaluated NOT_SATISFIED when this grouping was created, inheriting a
pre-existing failure against its own child's NECESSARY criterion. The cause
was a granularity mismatch in the criterion rather than a gap in the entry:
ontology closure runs downward, so an entry annotated at an ancestor of the
process a criterion names never satisfies it, and both criteria named only
specific branches (GO:0006487, GO:0006493) while the entry annotated
GO:0009100 glycoprotein metabolic process. The entry was right to decline a
branch — its cited result is hypoglycosylated LAMP2, which the source does not
resolve to N- or O-linked, and UGP2's lesion is UDP-glucose supply feeding
several branches at once, which is why it sits in the multiple-pathway child
at all.
Fixed on both sides, each change standing on its own. The entry node moved to
GO:0009101 glycoprotein biosynthetic process: more specific than what it
carried, since it excludes the glycoprotein catabolism GO:0009100 also covers,
and still branch-agnostic, so it claims no more than the source does. The
child criterion and this disjunction each gained a GO:0009101 operand, which
is the level the child's own rationale always described — grouping members "at
the pathway-placement level" — and which closure makes subsume the named-branch
operands, so nothing that satisfied them stops doing so. Note GO:0006486, the
term an editor might reach for as "protein glycosylation", is **obsolete** —
GO labels it "obsolete protein glycosylation" and records
term_replaced_by GO:0009101, which is why GO:0009101 is both the replacement
and the common ancestor of the N- and O-linked classes. An earlier version of
this note said GO:0006486 did not exist; that came from passing the CURIE to
an OLS *text* search, which matches nothing, and reading the empty result as
absence. Resolve a CURIE by its term endpoint, not by searching for it.
Resolved — MONDO closure, and it found a problem. The closure was declared
UNKNOWN because the configured ols:mondo adapter cannot expand a class's
descendants. Inverting the question removed the need to: instead of expanding
MONDO:0015286 downward and testing members against the result, each member's
own term is walked upward and the class looked up in its ancestor set. That is
bounded per member, needs no 588 MB local build, and the OLS REST endpoint
serves it directly. The result is in the mapping's consistency block: 24 of 38
members descend from the mapped class, 14 do not, and the umbrella's concept
therefore contains the MONDO class rather than equalling it. Whether the
predicate should move from skos:exactMatch to skos:broadMatch is a live
question with tooling consequences and is argued in that block rather than
decided here.
Coverage of the ICIMD category-18 classification itself is thin — 20 entries
KB-wide, and only 20 of this grouping's 38 transitively held diseases carry a
value (every one of those 20 KB-wide entries is now held here, which is why
the SUFFICIENT criterion reports no candidates). That is why the ICIMD criterion is SUFFICIENT (a discovery lever) rather
than NECESSARY (an audit of the listed members).